Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1Other 1

Conditions

Carcinoma, Non-Small-Cell Lung 117Squamous Cell Carcinoma of Head and Neck 61Triple Negative Breast Neoplasms 55Melanoma 54Lung Neoplasms 49Neoplasm Metastasis 47Breast Neoplasms 42Neoplasms 38Colorectal Neoplasms 37Head and Neck Neoplasms 26Endometrial Neoplasms 25Carcinoma, Renal Cell 25Ovarian Neoplasms 22Uterine Cervical Neoplasms 21Stomach Neoplasms 21Carcinoma, Transitional Cell 21Urinary Bladder Neoplasms 20Parkinson Disease 4, Autosomal Dominant Lewy Body 19Recurrence 16Esophageal Neoplasms 16Pancreatic Neoplasms 15Carcinoma, Hepatocellular 14Sarcoma 12Glioblastoma 12Carcinoma, Squamous Cell 12Prostatic Neoplasms 11Esophageal Squamous Cell Carcinoma 11Carcinoma 11Brain Neoplasms 10Carcinoma, Merkel Cell 9

Interventions

trametinib 1sotorasib 1selpercatinib 1pembrolizumab 1osimertinib 1lorlatinib 1dabrafenib 1cemiplimab 1brigatinib 1alectinib 1Surveys and Questionnaires 1Pemetrexed 1Paclitaxel 1Nivolumab 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Sexual Dysfunction, Physiological × pembrolizumab × Clear all
NCT06532149 2024-08-09

EROS

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Recruiting
80 enrolled
OtherThoracic

Carcinoma, Non-Small-Cell Lung, Eunuchism, Erectile Dysfunction, Sexual Dysfunction, Physiological

Data powered by HemOnc (CC BY 4.0) Colophon âš¡